Takeda Pharmaceuticals America, Inc. and Lundbeck, LLC
As state and federal budgets get tighter, spending on mental illness has dramatically fallen -- contributing to significant gaps in America’s mental health safety net. Cash-strapped Medicaid programs bear a large part of the burden of caring for those with mental illness and these programs’ budget troubles are only expected grow.
On Thursday, February 26, The Hill will host a timely and thought-provoking conversation on the economic and human consequences of cost-cutting policies that limit access to treatment.
DID YOU MISS IT? VIEW THE FULL EVENT VIDEO HERE.
Sen. CHRIS MURPHY (D-CT)
Rep. TIM MURPHY (R-PA-18)
ALLEN DOEDERLEIN, President, Depression & Bipolar Support Alliance
AZFAR MALIK, M.D., CEO & Chief Medical Officer, CenterPointe Hospital (St. Louis, MO)
RON MANDERSCHEID, Ph.D., Executive Director, National Association of County Behavioral Health & Developmental Disability Directors
MATT SALO, Executive Director, National Association of Medicaid Directors
SETH SEABURY, Ph.D., USC Schaeffer Center for Health Policy & Economics
BOB CUSACK, Editor in Chief, The Hill
USC Schaeffer Center for Health Policy & Economics
This event is co-sponsored by Takeda Pharmaceuticals America, Inc. and Lundbeck, LLC
For updates on this and other events, follow us @TheHillEvents!